Paper20052341
Idarubicin plus behenoyl cytarabine and 6-thioguanine compares favorably with idarubicin plus cytarabine-based regimen for children with previously untreated acute myeloid leukemia: 10-year retrospective, multicenter study in Korea.
Lee DH and 14 others. J Korean Med Sci, 2010. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. Idarubicin plus behenoyl cytarabine and 6-thioguanine compares favorably with idarubicin plus cytarabine-based regimen for children with previously untreated acute myeloid leukemia: 10-year retrospective, multicenter study in Korea. Papers, record 20052341. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20052341
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Idarubicin plus behenoyl cytarabine and 6-thioguanine compares favorably with idarubicin plus cytarabine-based regimen for children with previously untreated acute myeloid leukemia: 10-year retrospective, multicenter study in Korea.
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Combined Chemotherapy Protocols | Major topic |
| Cytarabine | Major topic |
| Idarubicin | Major topic |
| Leukemia, Myeloid, Acute | Major topic |
| Thioguanine | Major topic |
| Adolescent | |
| Child | |
| Child, Preschool | |
| Combined Modality Therapy | |
| Cytogenetics | |
| Female | |
| Hematopoietic Stem Cell Transplantation | |
| Humans | |
| Infant | |
| Infant, Newborn | |
| Male | |
| Republic of Korea | |
| Retrospective Studies | |
| Survival Analysis | |
| Young Adult |
Source PubMed
References25
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 188440 | Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. | Br J Haematol | 1976 | https://conductscience.org/library/papers/188440 | PubMed |
| 2 | 1277182 | Antitumor activities of newly synthesized N4-acyl-1-beta-D-arabinofuranosylcytosine. | Cancer Res | 1976 | https://conductscience.org/library/papers/1277182 | PubMed |
| 3 | 16304571 | Long-term results in children with AML: NOPHO-AML Study Group--report of three consecutive trials. | Leukemia | 2005 | https://conductscience.org/library/papers/16304571 | PubMed |
| 4 | 16912228 | Clinical implications of FLT3 mutations in pediatric AML. | Blood | 2006 | https://conductscience.org/library/papers/16912228 | PubMed |
| 5 | 8174198 | Nationwide randomized comparative study of daunorubicin and aclarubicin in combination with behenoyl cytosine arabinoside, 6-mercaptopurine, and prednisolone for previously untreated acute myeloid leukemia. | Cancer Chemother Pharmacol | 1994 | https://conductscience.org/library/papers/8174198 | PubMed |
| 6 | 872077 | N4-Behenoyl-1-beta-D-arabinofuranosylcytosine as a potential new antitumor agent. | Cancer Res | 1977 | https://conductscience.org/library/papers/872077 | PubMed |
| 7 | 17713551 | Clinical characteristics and outcomes in patients with t(8;21) acute myeloid leukemia in Japan. | Leukemia | 2008 | https://conductscience.org/library/papers/17713551 | PubMed |
| 8 | 16304570 | Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials. | Leukemia | 2005 | https://conductscience.org/library/papers/16304570 | PubMed |
| 9 | 15830007 | Postremission therapy for children with acute myeloid leukemia: the children's cancer group experience in the transplant era. | Leukemia | 2005 | https://conductscience.org/library/papers/15830007 | PubMed |
| 10 | 8916313 | Induction chemotherapy with idarubicin plus N4-behenoyl-1-beta-D-arabinofuranosylcytosine in acute myelogenous leukemia: a newly designed induction regimen--a prospective, cooperative multicenter study. | Semin Hematol | 1996 | https://conductscience.org/library/papers/8916313 | PubMed |
| 11 | 10446497 | Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy. The Japan Adult Leukemia Study Group. | Int J Hematol | 1999 | https://conductscience.org/library/papers/10446497 | PubMed |
| 12 | 17222748 | The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myeloid leukemia in children: an evidence-based review. | Biol Blood Marrow Transplant | 2007 | https://conductscience.org/library/papers/17222748 | PubMed |
| 13 | 2253209 | Effects of N4-behenoyl-1-beta-D-arabinofuranosylcytosine on blast progenitors of acute myeloblastic leukemia. | Cancer Res | 1990 | https://conductscience.org/library/papers/2253209 | PubMed |
| 14 | 16110030 | Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): a Cancer and Leukemia Group B study. | J Clin Oncol | 2005 | https://conductscience.org/library/papers/16110030 | PubMed |
| 15 | 6850647 | Pharmacokinetics of N4-behenoyl-1-beta-D-arabinofuranosylcytosine in patients with acute leukemia. | Cancer Res | 1983 | https://conductscience.org/library/papers/6850647 | PubMed |
| 16 | 16304572 | Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials. | Leukemia | 2005 | https://conductscience.org/library/papers/16304572 | PubMed |
| 17 | 3164731 | Clinical use of intermediate to high dose of N4-behenoyl-1-beta-D-arabinofuranosylcytosine in children with acute leukemia. | J Clin Pharmacol | 1988 | https://conductscience.org/library/papers/3164731 | PubMed |
| 18 | 12162758 | Clinical pharmacokinetics of cytarabine formulations. | Clin Pharmacokinet | 2002 | https://conductscience.org/library/papers/12162758 | PubMed |
| 19 | 16304569 | Pediatric acute myeloid leukemia: international progress and future directions. | Leukemia | 2005 | https://conductscience.org/library/papers/16304569 | PubMed |
| 20 | 3465875 | Behenoyl cytosine arabinoside, daunorubicin, 6-mercaptopurine, and prednisolone combination therapy for acute myelogenous leukemia in adults and prognostic factors related to remission duration and survival length. | J Clin Oncol | 1986 | https://conductscience.org/library/papers/3465875 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 29662859 | Improvement of treatment outcome over 2 decades in children with acute myeloid leukemia. | Blood Res | 2018 | https://conductscience.org/library/papers/29662859 | PubMed |
| 23341720 | Growth after hematopoietic stem cell transplantation in children with acute myeloid leukemia. | J Korean Med Sci | 2013 | https://conductscience.org/library/papers/23341720 | PubMed |
| 20508938 | Double umbilical cord blood transplantation for children and adolescents. | Ann Hematol | 2010 | https://conductscience.org/library/papers/20508938 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| FLT3 | 2322 | PubTator's text mining | https://conductscience.org/library/genes/2322 | NCBI Gene |
| HLA-A | 3105 | PubTator's text mining | https://conductscience.org/library/genes/3105 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20052341
GET https://conductscience.org/api/papers/v1/20052341/references?page=2